Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

NCT02072928 · clinicaltrials.gov ↗
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan